Xin Lang Cai Jing·2025-12-25 05:39Group 1 - The core viewpoint of the news is that Sino Medical has seen a significant increase in its stock price, rising by 5.12% to reach 18.69 CNY per share, with a total market capitalization of 7.776 billion CNY [1] - Sino Medical, established on September 21, 2007, and listed on October 30, 2019, specializes in the research, production, and sales of high-end interventional medical devices, focusing on cardiovascular, cerebrovascular, and structural heart disease treatments [1] - The revenue composition of Sino Medical is primarily from stents (59.76%), followed by balloons (32.68%), and other products (7.56%) [1] Group 2 - From the perspective of fund holdings, Sino Medical is a major investment for the Guotai Haitong Asset Management, with its fund holding 444,300 shares, representing 0.89% of the fund's net value, making it the top heavy stock [2] - The Guotai Haitong Quantitative Stock Mixed Fund A (016466) has achieved a year-to-date return of 33.18%, ranking 2673 out of 8087 in its category, and a one-year return of 30.85%, ranking 2722 out of 8071 [2] - The fund manager, Hu Chonghai, has a tenure of 4 years and 12 days, with the fund's total asset size at 13.684 billion CNY, achieving a best return of 70.69% during his management [3]